Nisa Investment Advisors
KRON

Nisa Investment Advisors’s Kronos Bio KRON Stock Holding History

Nisa Investment Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-216
Closed -$372 – 2806
2023
Q2 		$372 Hold
216
– – ﹤0.01% 2621
2023
Q1 		$0 Hold
216
– – ﹤0.01% 2607
2022
Q4 		$0 Sell
216
-4,084
-95% -$9.4K ﹤0.01% 2641
2022
Q3 		$13K Hold
4,300
– – ﹤0.01% 2137
2022
Q2 		$16K Buy
4,300
+1,900
+79% +$8.61K ﹤0.01% 2099
2022
Q1 		$17K Buy
+2,400
New +$20.5K ﹤0.01% 2090

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nisa Investment Advisors's KRON Position: Q3 2023 in Review

Nisa Investment Advisors sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 216 shares — an estimated $372 sold.

Nisa Investment Advisors first reported a position in KRON in Q1 2022 and held it in 6 quarters. The position peaked at $17K in Q1 2022. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Nisa Investment Advisors reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 216 Kronos Bio shares in Q3 2023, an estimated $372.
  • Nisa Investment Advisors first reported a position in Kronos Bio in Q1 2022 and held it in 6 quarters.
  • Nisa Investment Advisors's Kronos Bio position peaked at $17K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.